Category: 4. Health

“We were surprised to find that zeaxanthin, already…

The Trump administration announced late last month “bold actions to tackle the autism epidemic.” President…

President Trump and Pfizer announced a deal to cut drug pricing yesterday. And it looks like the pharmaceutical giant got the better end of it. Signed at a showy news conference on Tuesday, the agreement gives CEO Albert Bourla and his company a reprieve from threatened tariffs and something of a truce from an Administration that he had been battling. It was a win so…

The latest breakthrough in Nature demonstrates something unprecedented: the large-scale use of transformer-based large language models (LLMs) to model how human disease unfolds across lifetimes. While AI chatbots like ChatGPT have captured headlines for mimicking conversation, this work shows their potential to transform healthcare. For the first time, researchers have applied the architecture of generative AI to predict…

The headlines from Congress’s passage of the Big Beautiful Bill have faded, but its consequences are only beginning. Designed to postpone its harshest health impacts until after the 2026 mid-term elections, the law is colliding with a new reality: as of October 1, the federal government has shut down, triggered by an impasse over the future of tax credits for…

In this week’s edition of InnovationRx, we look at the Haitian immigrant who built a $6 billion company treating brain diseases, the drugs RFK Jr. may target after Tylenol, Northwell’s new CEO, and more. To get it in your inbox, subscribe here.

On Tuesday, President Trump announced a new direct-to-consumer website called TrumpRx that would be operated by the federal government and offer drugs at discounted prices. Pfizer…

In a study published in Nature Communications, the researchers demonstrate how the tool, called DOLPHIN, could one day be used by doctors to catch diseases earlier and guide treatment options.

“This tool has the potential to help doctors match patients with the therapies most likely to work for them, reducing trial-and-error in treatment,”…

If you don’t have a “Ghostface” of a chance of getting screened for colon cancer when you reach 45 years of age, Matt Lillard has something to tell you. The 55-year-old actor played Stu Macher in…

Long-term remission in multiple myeloma—a blood cancer once considered incurable—is finally becoming a reality. A single…